# Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults

> **NCT01000571** · — · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 104 (actual)

## Conditions studied

- H1N1 Pandemic Flu

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01000571
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2011-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01000571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01000571, "Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01000571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*